Association between vitamin B12 deficiency and long-term use of acid-lowering agents: A systematic review and meta-analysis

Internal Medicine Journal

Volumn 45, Issue 4, 2015, Pages 409-416

  Jung, S B ^a,b   Nagaraja, V ^b,c   Kapur, A ^a,b,d   Eslick, G D ^c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Acid lower suppress; Cobalamin deficiency; Histamine receptor antagonist; Proton pump inhibitor; Vitamin B12 deficiency

Indexed keywords

ACID LOWERING AGENT; CYANOCOBALAMIN; GASTROINTESTINAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; DRUG USE; HUMAN; LONG TERM CARE; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW;

EID: 84964303665     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12697     Document Type: Article

References (40)

1. IMS Institute for Healthcare Informatics. Medicine use and Shifting Costs of Healthcare: A Review of the use of Medicines in the United States in 2013. Parsippany (NJ): IMS Institute for Healthcare Informatics; 2014.
2. Kapadia C. Cobalamin (vitamin B12) Deficiency: Is it a Problem for Our Aging Population and Is the Problem Compounded by Drugs That Inhibit Gastric Acid Secretion? New Haven (CT): Yale University School of Medicine 2000; 4-6.
3. Rozgony NR, Fang C, Kuczmarski MF, Bob H. Vitamin B12 Deficiency is Linked with Long-term Use of Proton Pump Inhibitors in Institutionalized Older Adults: Could a Cyanocobalamin Nasal Spray be Beneficial? Newark (DE): University of Delaware; 2010; 87-99.
4. Howden CW. Vitamin B12 levels during prolonged treatment with proton pump inhibitors. J Clin Gastroenterol 2000; 30: 29-33.
5. Lachner C, Steinle NI, Regenold WT. The neuropsychiatry of vitamin B12 deficiency in elderly patients. J Neuropsychiatry Clin Neurosci 2012; 24: 5-15.
6. Abraham NS. Proton pump inhibitors: potential adverse effects. Curr Opin Gastroenterol 2012; 28: 615-620.
7. Langan RC, Zawistoski, KJ. Update on vitamin B12 deficiency. Am Fam Physician 2011; 83: 1425-1430.
8. Force RW, Meeker AD, Cady PS, Culbertson VL, Force WS, Kelley CM etal. Increased Vitamin B12 Requirement Associated with Chronic Acid Suppression Therapy. Pocatello (ID): Idaho State University; 2003; 490-493.
9. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-1012.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
12. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
13. Orwin R. A fail-safe N for effect size in meta-analysis. J Educ Stat 1983; 8: 157-159, 1983.
14. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M etal. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014. Available from URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
15. Mitchell SL, Rockwood K. The association between antiulcer medication and initiation of cobalamin replacement in older persons. J Clin Epidemiol 2001; 54: 531-534.
16. Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol 2004; 57: 422-428.
17. Cotter PE, O'Keeffe ST. Use of proton pump inhibitors is not associated with Vitamin B12 deficiency and in older hospital patients: a case control study. Eur Geriatr Med 2011; 2: 253-255.
18. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 2013; 310: 2435-2442.
19. Canadian Study of Health and Aging Working Group. Canadian study of health and aging: study methods and prevalence of dementia. CMAJ 1994; 150: 899-913.
20. Graham JE, Rockwood K, Beattie BL, McDowell I, Eastwood R, Gauthier S. Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology 1996; 15: 246-256.
21. Bellou A, Aimone-Gastin I, De Korwin JD, Bronowicki JP, Moneret-Vautrin A, Nicolas JP etal. Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy. J Intern Med 1996; 240: 161-164.
22. Ruscin JM, Page RL 2nd, Valuck RJ. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor. Ann Pharmacother 2002; 36: 812-816.
23. Hirschowitz BI, Worthington J, Mohnen J. Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 2008; 27: 1110-1121.
24. Termanini B, Gibril F, Sutliff VE, Yu F, Venzon DJ, Jensen RT. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. Am J Med 1998; 104: 422-430.
25. Marcuard SP, Albernaz L, Khazanie PG. Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12). Ann Intern Med 1994; 120: 211-215.
26. Saltzman JR, Kemp JA, Golner BB, Pedrosa MC, Dallal GE, Russell RM. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. J Am Coll Nutr 1994; 13: 584-591.
27. Schenk BE, Festen HP, Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG. Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin. Aliment Pharmacol Ther 1996; 10: 541-545.
28. Salom IL, Silvis SE, Doscherholmen A. Effect of cimetidine on the absorption of vitamin B12. Scand J Gastroenterol 1982; 17: 129-131.
29. Steinberg WM, King CE, Toskes PP. Malabsorption of protein-bound cobalamin but not unbound cobalamin during cimetidine administration. Dig Dis Sci 1980; 25: 188-191.
30. Belaiche J, Zittoun J, Marquet J, Nurit Y, Yvart J. [Effect of ranitidine on secretion of gastric intrinsic factor and absorption of vitamin B 12]. Gastroentérologie clinique et biologique 1983; 7: 381-384.
31. Streeter AM, Goulston KJ, Bathur FA, Hilmer RS, Crane GG, Pheils MT. Cimetidine and malabsorption of cobalamin. Digest Dis Sci 1982; 27: 13-16.
32. Hamborg B, Kittang E, Schjonsby H. The effect of ranitidine on the absorption of food cobalamins. Scand J Gastroenterol 1985; 20: 756-758.
33. Dharmarajan TS, Kanagala MR, Murakonda P, Lebelt AS, Norkus EP. Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc 2008; 9: 162-167.
34. Scarlett JD, Read H, O'Dea K. Protein-bound cobalamin absorption declines in the elderly. Am J Hematol 1992; 39: 79-83.
35. ter Heide H, Hendriks HJ, Heijmans H, Menheere PP, Spaapen LJ, Bakker JA etal. Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B(12) deficiency? J Pediatr Gastroenterol Nutr 2001; 33: 342-345.
36. Thomson ABR, Sauve MD, Kassam N, Kamitakahara H. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol 2010; 16: 2323-2330.
37. den Elzen WPJ, Groeneveld Y, de Ruijter W, Souverijn JHM, le Cessie S, Assendelft WJJ etal. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals. Aliment Pharmacol Ther 2008; 27: 491-497.
38. Lee TJ, Fennerty MB, Howden CW. Systematic review: is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease? Aliment Pharmacol Ther 2004; 20: 1241-1251.
39. Pace F, Tonini M, Pallotta S, Molteni P, Porro GB. Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken 'on-demand. Aliment Pharmacol Ther 2007; 26: 195-204.
40. Zacny J, Zamakhshary M, Sketris I, Veldhuyzen van Zanten S. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients. Aliment Pharmacol Ther 2005; 21: 1299-1312.